Low Volume, microbatch-under oil style crystallization experiment
|
Nanovolume drops of protein solution are sufficient to fill an entire CrystalCard with ca. 800 individual crystallization experiments. Each aqueous droplet (plug) forms at the mixer where protein, buffer and a precipitant combine. The plugs spontaneously form when coming in contact with the inert, immiscible carrier fluid.
: Plug Generation and Crystal formation
|
|

NO CROSS CONTAMINATION!
A thin layer of carrier fluid between the plug and the wall of the microcapillary prevents any cross-contamination, making each plug a separate and distinct experiment.
|
Diffraction-ReadyTM Crystals
|
Crystals that are grown within Peel-Apart™CrystalCards are directly accessible to manual harvesting.
A plastic seal is peeled off to give access to the crystals for extraction using a traditional cryo loop. Alternatively, crystals may be subjected in-situ to X-ray diffraction.
: Crystal Harvesting
|

|
Optimization Screening
|
The MPCS™ uses on-chip formulation to generate fine concentration gradients of a crystallization condition.
|

Crystal growth optimization experiment with ribose-phosphate pyrophosphokinase
Reference: Gerdts et. al. Acta Cryst. (2008). D64, 1116-1122
|

Very fine gradients are generated over a series of plugs to carefully interrogate crystallization phase space. |
Sparse Matrix Screening
|
Using the Hybrid Mode, a fine chemical gradient screen experiment is carried out on a variety of crystallization cocktails. This is a combination of a crystal hit via sparse matrix screening and subsequent optimization.
|

Pre-formed cartridges of precipitants seperated by gas bubbles are generated. The MPCS™ dispenses the pre-formed cartridges with a stream of protein solution and buffer to form a concentration gradient for each precipitant.
|
In-situ X-ray Diffraction
Crystals grown in the CrystalCard were subjected in-situ to X-rays. Data collected at NE-CAT beamline 24ID-C at the Advanced Photon Source at Argonne National Laboratories.
Data was merged from three different crystals, yielding an electron density map with a resolution of 1.9Å. |
|

|
Microfluidic Seeding
Microcrystals in volumes as little as 0.5 uL from a previous crystallization experiment can be used to carry out microfludic seeding in the MPCS™.
|

|
Microcrystals are aspirated into a Teflon tube (a). The microcrystal-containing solution is used as one of the aqueous streams in the 3+1 mixer (b). The CrystalCard™ is filled with plugs that each contain one or a few small microcrystals to seed crystal growth (c).
|
No Dead Volume
Protein samples are used in their entirety in the protein crystallization trial. Prior to loading the protein solution, the syringe and Teflon tubing are back-filled with a carrier fluid (cf).
 |
This back-filling method ensures that every nanoliter of protein sample is pumped into the CrystalCard. |
Recent Successes
The MPCS™was used at deCODE biostructures, Inc. to optimize the crystallization of an infectious disease target protein (Methionine-R-sulfoxide Reductase of Burkholderia pseudomallei).
Experiments were carried out at the Accelerated Technologies Center for Gene to 3D Structure in collaboration with the Seattle Structural Genomics Center for Infectious Diseases.
| |


Crystals of methionine-R-sulfoxide reductase and methylisocitrate lyase were grown by performing gradient optimization experiments in MPCS™ CrystalCards™. The efficiency of the structure determination process was improved while not requiring additional protein production.
Reference: Gerdts et. al. Acta Cryst. (2008). D64, 1116-1122
(1.7 Angstrom Structure deposited in PDB under 3CXK)

|